Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Thalamas

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Psychopharmacology|August 9, 2021
Functional connectivity and cognitive changes after donepezil treatment in healthy participantsP Péran, A S Salabert, T Dondaine, et al.
Neurology|September 30, 2010
Motor activation in multiple system atrophy and Parkinson disease: a PET studyP Payoux, C Brefel-Courbon, F Ory-Magne, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 2, 2001
Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's diseaseO Rascol, I Arnulf, H Peyro-Saint Paul, et al.
Archives of Neurology|February 15, 2001
Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson diseaseO Rascol, J G Nutt, O Blin, et al.
International Journal of Obesity (2005)|August 28, 2013
Effect of endurance training on skeletal muscle myokine expression in obese men: identification of apelin as a novel myokineA Besse-Patin, E Montastier, C Vinel, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Psychopharmacology|August 9, 2021
Functional connectivity and cognitive changes after donepezil treatment in healthy participantsP Péran, A S Salabert, T Dondaine, et al.
Neurology|September 30, 2010
Motor activation in multiple system atrophy and Parkinson disease: a PET studyP Payoux, C Brefel-Courbon, F Ory-Magne, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 2, 2001
Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's diseaseO Rascol, I Arnulf, H Peyro-Saint Paul, et al.
Archives of Neurology|February 15, 2001
Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson diseaseO Rascol, J G Nutt, O Blin, et al.
International Journal of Obesity (2005)|August 28, 2013
Effect of endurance training on skeletal muscle myokine expression in obese men: identification of apelin as a novel myokineA Besse-Patin, E Montastier, C Vinel, et al.
Pageof 4